Skip to content

DR. SOFIE MASSCHELEIN

Active
Private limited companyfounded 2018active for 8 yearsDiksmuidse Heirweg 12, 8210 Zedelgem, BelgiumKBO/BCE: BE 0700.929.918
Summary

DR. SOFIE MASSCHELEIN has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €112,618 and a net result of €79,518. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 30% of 20,612 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€307,446total assets 2025
Equity
€112,618
Profit
€79,518
Turnover not published (micro format)
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 59 days early3 deeds in the Belgian Official Gazette
Why 93lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.55, cash €221,821Size: total assets €307,446Figures for financial year 2025 (filed 02-06-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 42% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 62-38
equity 36.6% of total assets
Liquidity 67-33
short-term debt 63.4% · cash 72.1%
Profitability 100=
return on assets 25.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,124 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025highest value 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €10,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.55, compared with 15.67 in 2024, above the usual 1.5; short-term debt: 63.4% and cash: 72.1% of total assets), but 63.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 30% on solvency, 46% on liquidity, 80% on profitability and 12% on growth.

The bankruptcy probability was computed on 26-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.55, cash €221,821
NBB · annual accounts
lowers risk · Size: total assets €307,446
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 02-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 02-06-2026, 59 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
59 days early
2024
48 days early
2023
36 days early
2022
26 days early
2021
18 days early
2020
22 days early
2019
44 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 36 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 26 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
27-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Highest result from 2018 to 2025net €125,120 ▲33.1%

Financials · financial year 2025, micro format

Equity
€112,618▼ 52.5%
2024 · €236,879
Total assets
€307,446▲ 21.7%
2024 · €252,616
Net result
€79,518▼ 36.4%
2024 · €125,120
Working capital
€107,235▼ 53.5%
2024 · €230,829
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

The operating result falls in 2025; 2025 is 38% below 2024 and is the lowest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€99,123 2025 Net result€79,518 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€70,970-€86,681▲ 22.1%€89,651▲ 3.4%€147,283▲ 64.3%€121,448▼ 17.5%€131,226▲ 8.1%€160,107▲ 22.0%€99,123▼ 38.1%
Net result€56,235-€68,664▲ 22.1%€72,431within the sector's middle half▲ 5.5%€115,607above the sector's middle half▲ 59.6%€96,335within the sector's middle half▼ 16.7%€94,018within the sector's middle half▼ 2.4%€125,120above the sector's middle half▲ 33.1%€79,518within the sector's middle half▼ 36.4%
Equity€67,835-€142,699▲ 110%€214,330within the sector's middle half▲ 50.2%€329,937within the sector's middle half▲ 53.9%€18,600below the sector's middle half▼ 94.4%€112,618within the sector's middle half▲ 505%€236,879within the sector's middle half▲ 110%€112,618within the sector's middle half▼ 52.5%
Total assets€100,388-€168,983▲ 68.3%€260,485within the sector's middle half▲ 54.1%€349,813within the sector's middle half▲ 34.3%€135,651below the sector's middle half▼ 61.2%€134,162within the sector's middle half▼ 1.1%€252,616within the sector's middle half▲ 88.3%€307,446within the sector's middle half▲ 21.7%
Debt€32,554-€26,285▼ 19.3%€46,155▲ 75.6%€19,876▼ 56.9%€117,051▲ 489%€21,544▼ 81.6%€15,736▼ 27.0%€194,828▲ 12×
Working capital€67,835-€133,134▲ 96.3%€206,933within the sector's middle half▲ 55.4%€323,930above the sector's middle half▲ 56.5%€14,323below the sector's middle half▼ 95.6%€111,981within the sector's middle half▲ 682%€230,829within the sector's middle half▲ 106%€107,235within the sector's middle half▼ 53.5%
Solvency67.6%-84.4%▲ 16.9pp82.3%above the sector's middle half▼ 2.2pp94.3%above the sector's middle half▲ 12.0pp13.7%below the sector's middle half▼ 80.6pp83.9%within the sector's middle half▲ 70.2pp93.8%above the sector's middle half▲ 9.8pp36.6%within the sector's middle half▼ 57.1pp
Current ratio3.08-6.59▲ 3.505.65within the sector's middle half▼ 0.9417.30above the sector's middle half▲ 11.651.12below the sector's middle half▼ 16.176.20within the sector's middle half▲ 5.0815.67above the sector's middle half▲ 9.471.55within the sector's middle half▼ 14.12
Return on assets (ROA)56.0%-40.6%▼ 15.4pp27.8%above the sector's middle half▼ 12.8pp33.0%above the sector's middle half▲ 5.2pp71.0%above the sector's middle half▲ 38.0pp70.1%above the sector's middle half▼ 0.9pp49.5%above the sector's middle half▼ 20.5pp25.9%within the sector's middle half▼ 23.7pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €307,446
Fixed assets €5,383 ▼ 11.0%
Current assets €302,063 ▲ 22.5%
Equity and liabilities €307,446
Equity €112,618 ▼ 52.5%
Debt €194,828 ▲ 12×
Debt's share of the balance-sheet total rises from 6.2% to 63.4%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€99,790▼
2024 · €161,369
Cash flow
€80,186▼
2024 · €126,383
Debt to equity
1.73▲
2024 · 0.07
ROE
70.6%▲
2024 · 52.8%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€194,828▲
2024 · €15,736
Income taxes
€20,787▼
2024 · €36,199
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 26,974 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 94.8% are still going.

  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.6% went bankrupt
3.5% stopped otherwise
94.8% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,475 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 26,974 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 45 lines
Balance sheet Code20242025
Assets
Total assets20/58€252,616€307,446▲
Fixed assets21/28€6,051€5,383▼
Tangible fixed assets22/27€6,051€5,383▼
Furniture and vehicles24€0-
Other tangible fixed assets26€6,051€5,383▼
Current assets29/58€246,565€302,063▲
Amounts receivable after more than one year29€50,000€50,000=
Other amounts receivable291€50,000€50,000=
Amounts receivable within one year40/41€13,743€25,053▲
Trade receivables40-€33
Other amounts receivable41€13,743€25,020▲
Cash at bank and in hand54/58€177,939€221,821▲
Deferred charges and accrued income490/1€4,883€5,189▲
Equity and liabilities
Total equity and liabilities10/49€252,616€307,446▲
Equity10/15€236,879€112,618▼
Contributions10/11€18,600€18,600=
Reserves13€218,279€94,018▼
Distributable reserves133€218,279€94,018▼
Profit (loss) carried forward14€0€0=
Amounts payable17/49€15,736€194,828▲
Amounts payable within one year42/48€15,736€194,828▲
Trade debts44€50€20▼
Suppliers440/4€50€20▼
Taxes, remuneration and social security45€12,749€6,550▼
Taxes450/3€10,399€4,200▼
Remuneration and social security454/9€2,350€2,350=
Other amounts payable47/48€2,937€188,258▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1,262€668▼
Other operating charges640/8€733€864▲
Gross operating margin9900€162,102€100,655▼
Operating profit (loss)9901€160,107€99,123▼
Financial income75/76B€1,500€1,500=
Recurring financial income75€1,500€1,500=
Financial charges65/66B€287€318▲
Recurring financial charges65€287€318▲
Profit (loss) for the period before taxes9903€161,320€100,305▼
Income taxes67/77€36,199€20,787▼
Profit (loss) for the period9904€125,120€79,518▼
Profit (loss) for the period to be appropriated9905€125,120€79,518▼
Appropriation of the result
Profit (loss) to be appropriated9906€125,120€79,518▼
Transfer from equity791/2-€124,261
Transfer to equity691/2€124,261€0▼
To other reserves6921€124,261€0▼
Profit to be distributed694/7€859€203,780▲
Return on contributions (dividend)694€859€203,780▲

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€0€3,003€3,003€3,003€3,640€3,640€1,262€668▼ 47.1%
Other operating charges640/8---€629€591€499€733€864▲ 17.9%
Gross operating margin9900€71,225€90,279€93,230€150,916€125,679€135,366€162,102€100,655▼ 37.9%
Operating profit (loss)9901€70,970€86,681€89,651€147,283€121,448€131,226€160,107€99,123▼ 38.1%
Financial income75/76B---€1,500€1,500€1,501€1,500€1,500=
Recurring financial income75€0€0€1,500€1,500€1,500€1,501€1,500€1,500=
Financial charges65/66B---€149€301€229€287€318▲ 10.5%
Recurring financial charges65€20€91€165€149€301€229€287€318▲ 10.5%
Profit (loss) for the period before taxes9903€70,950€86,590€90,986€148,634€122,647€132,498€161,320€100,305▼ 37.8%
Income taxes67/77€14,715€17,926€18,555€33,027€26,312€38,480€36,199€20,787▼ 42.6%
Profit (loss) for the period9904€56,235€68,664€72,431€115,607€96,335€94,018€125,120€79,518▼ 36.4%
Profit (loss) for the period to be appropriated9905€56,235€68,664€72,431€115,607€96,335€94,018€125,120€79,518▼ 36.4%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€100,388€168,983€260,485€349,813€135,651€134,162€252,616€307,446▲ 21.7%
Formation expenses20€0--------
Fixed assets21/28€0€12,014€9,010€6,007€4,277€637€6,051€5,383▼ 11.0%
Intangible fixed assets21€0--------
Tangible fixed assets22/27€0€12,014€9,010€6,007€4,277€637€6,051€5,383▼ 11.0%
Furniture and vehicles24---€6,007€4,277€637€0--
Other tangible fixed assets26------€6,051€5,383▼ 11.0%
Financial fixed assets28€0--------
Current assets29/58€100,388€156,970€251,475€343,807€131,374€133,525€246,565€302,063▲ 22.5%
Amounts receivable after more than one year29---€50,000€50,000€50,000€50,000€50,000=
Other amounts receivable291---€50,000€50,000€50,000€50,000€50,000=
Stocks and contracts in progress3€0--------
Amounts receivable within one year40/41€0€392€0€23,635€2,595€7,321€13,743€25,053▲ 82.3%
Trade receivables40-------€33-
Other amounts receivable41---€23,635€2,595€7,321€13,743€25,020▲ 82.1%
Current investments50/53€0--------
Cash at bank and in hand54/58€99,771€155,672€197,272€265,898€74,772€72,421€177,939€221,821▲ 24.7%
Deferred charges and accrued income490/1---€4,273€4,008€3,784€4,883€5,189▲ 6.3%
Equity and liabilities
Total equity and liabilities10/49€100,388€168,983€260,485€349,813€135,651€134,162€252,616€307,446▲ 21.7%
Equity10/15€67,835€142,699€214,330€329,937€18,600€112,618€236,879€112,618▼ 52.5%
Contributions10/11€12,400€18,600-€18,600€18,600€18,600€18,600€18,600=
Reserves13€55,435€124,099€195,730€311,337€0€94,018€218,279€94,018▼ 56.9%
Non-distributable reserves130/1---€0-----
Reserves not available under the articles1311---€0-----
Distributable reserves133---€311,337€0€94,018€218,279€94,018▼ 56.9%
Profit (loss) carried forward14€0--€0€0€0€0€0-
Provisions and deferred taxes16€0--------
Amounts payable17/49€32,554€26,285€46,155€19,876€117,051€21,544€15,736€194,828▲ 12×
Amounts payable after more than one year17€0--------
Amounts payable within one year42/48€32,554€23,835€44,542€19,876€117,051€21,544€15,736€194,828▲ 12×
Trade debts44€0--€98€478€0€50€20▼ 58.9%
Suppliers440/4---€98€478€0€50€20▼ 58.9%
Taxes, remuneration and social security45---€19,577€19,577€20,030€12,749€6,550▼ 48.6%
Taxes450/3---€17,227€17,227€17,680€10,399€4,200▼ 59.6%
Remuneration and social security454/9---€2,350€2,350€2,350€2,350€2,350=
Other amounts payable47/48---€201€96,996€1,514€2,937€188,258▲ 64×
Accrued charges and deferred income492/3---€0-----
Line20182019202020212022202320242025Change
Profit (loss) for the period9904€56,235€68,664€72,431€115,607€96,335€94,018€125,120€79,518▼ 36.4%
+ Depreciation and write-downs630€0€3,003€3,003€3,003€3,640€3,640€1,262€668▼ 47.1%
Operating cash flow (approximation)€56,235€71,668€75,435€118,611€99,975€97,658€126,383€80,186▼ 36.6%
Investment in fixed assets (approximation)--€15,017€0€0-€1,910€0-€6,676€0-
Change in cash-€55,902€41,600€68,626-€191,126-€2,352€105,518€43,883▼ 58.4%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (8)
Financial year Type Filed Reference
31-12-2025 micro format 02-06-2026 2026-00132721
31-12-2024 micro format 13-06-2025 2025-00137332
31-12-2023 micro format 25-06-2024 2024-00163876
31-12-2022 micro format 05-07-2023 2023-00203973
31-12-2021 micro format 13-07-2022 2022-20179743
31-12-2020 micro format 09-07-2021 2021-33300401
31-12-2019 micro format 17-06-2020 2020-17500597
31-12-2018 micro format 03-07-2019 2019-27800192

Similar companies · same sector, comparable size

Of the 9,155 active companies whose main activity is general medical practice (NACE 86210), figures are known for 6,444. 5,400 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 3 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

DR. SOFIE MASSCHELEIN was incorporated on 17 August 2018.1 Total assets rose from €100,388 in 2018 to €307,446 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
02-06
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
13-06
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
31-12
Financial Highest result from 2018 to 2025net €125,120 ▲33.1%
Operating result €160,107, net result €125,120, both a record.
31-12
Financial Liquidity more than doubledcurrent ratio 15.67
Current ratio from 6.20 to 15.67; short-term debt falls from €21,544 to €15,736.
31-12
Financial Equity above €200,000equity €236,879 ▲110%
A profit in every financial year since 2018 builds equity to €236,879.
25-06
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial Liquidity more than 5 timescurrent ratio 6.20
Current ratio from 1.12 to 6.20; short-term debt falls from €117,051 to €21,544.
31-12
Financial Equity above €100,000equity €112,618 ▲505%
A profit in every financial year since 2018 builds equity to €112,618.
05-07
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
13-07
NBB filing Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial Liquidity more than triplescurrent ratio 17.30
Current ratio from 5.65 to 17.30; short-term debt falls from €44,542 to €19,876.
09-07
NBB filing Annual accounts filed
financial year 2020 · micro format
Show earlier events
2020
31-12
Financial Equity above €200,000equity €214,330 ▲50.2%
A profit in every financial year since 2018 builds equity to €214,330.
17-06
NBB filing Annual accounts filed
financial year 2019 · micro format
2019
31-12
Financial Liquidity more than doubledcurrent ratio 6.59
Current ratio from 3.08 to 6.59; short-term debt falls from €32,554 to €23,835.
31-12
Financial Equity above €100,000equity €142,699 ▲110%
A profit in every financial year since 2018 builds equity to €142,699.
03-07
NBB filing Annual accounts filed
financial year 2018 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 3 deeds read
About the unread acts

We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded17-08-2018
Financial year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0700929918
Also 9925:BE0700929918
Registered 24-11-2023

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 27 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Zedelgem · 1 establishment unit since 2018
registered office establishment The establishment unit on the map
Ground area
1,414 m²
Building footprint
392 m²
Building volume
1,961 m³
2 parcels, Flanders · tallest building 8.5 m. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
Dr. Sofie Masschelein Burg.V. BVBA
Diksmuidse Heirweg 12A, 8210 ZedelgemGeneral medical practice
since 2018unit no. 2.279.488.419
2 parcels
Flanders 2 (100%)
Cadastral parcel Region Area Buildings Height / floors
31040A0236/00H000 Flanders 1,067 m² 1 · 177 m² 8.5 m · 2
31040A0236/00L000 Flanders 347 m² 1 · 214 m² 7.2 m · 2
How the parcels are linked
Good to know
Both parcels match the address exactly.